Drug Type Bispecific antibody |
Synonyms denecimig |
Target |
Action- |
Mechanism F10 inhibitors(Coagulation factor X inhibitors), factor IX inhibitors(Coagulation factor IX inhibitors) |
Therapeutic Areas- |
Active Indication- |
Inactive Indication- |
Originator Organization- |
Active Organization- |
Inactive Organization- |
License Organization- |
Drug Highest PhaseClinical |
First Approval Date- |
Regulation- |